Track Xvivo Perfusion AB (publ)'s inventory ($230M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest inventory for XVIPF is $230M as of June 2026. That compares with $270M in the prior-year period — down 15.4% year over year. Investors often review this figure alongside Xvivo Perfusion AB (publ)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, XVIPF's inventory moved from $270M to $230M — a 15.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Xvivo Perfusion AB (publ)'s operating scale or balance-sheet position.
A inventory figure of $230M for XVIPF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting XVIPF's inventory ($230M), review year-over-year change from $270M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.